Oncology practice transaction activity has been robust, with consistent interest from publicly traded companies, privately held oncology networks, and health systems. Oncology practices have also been increasingly involved in various partnerships, such as those with academic institutions and Cancer Centers of Excellence. Oncology acquisitions and partnerships are largely driven by increasing pressures on community oncology practices and the potential to achieve economies of scale, improve efficiency, and increase access to resources. Acquisitions and partnerships have the potential to improve patient outcomes by offering a broader range of treatments, expanding access to providers and clinical trials, and otherwise improving care through leverage of resources.
Read the full article: Cancer in Focus: Oncology Industry Outlook 2026 //
Source: https://www.stout.com/en/insights/industry-update/cancer-focus-oncology-industry-outlook-2026